Načítá se...
Biosimilars: what do patients need to consider?
A view from the EULAR Standing Committee of People with Arthritis/Rheumatism in Europe (SCPARE) on some of the issues that patients might wish to consider about biosimilars in shared decision-making discussions with their rheumatologist. The paper also points to the need for more information on bios...
Uloženo v:
| Vydáno v: | RMD Open |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4623364/ https://ncbi.nlm.nih.gov/pubmed/26535149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2015-000141 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|